Cell-matrix adhesive proteins: further therapeutic applications

References

• BROWN RA, MCFARLAND CD: Therapeutic uses of cellmatrix adhesive proteins. Cum. Opin. Thera. Patents. (1993) 3:1117–1140.
   Google Scholar
• YAMADA Y, KLEINMAN HK: Functional domains of celladhesion molecules Curr. Opin. Cell Biol. (1992) 4:819–823.
   PubMedGoogle Scholar
• ERICKSON HP: Tenascin-C, tenascin-R and tenascin-X: a
   Google Scholar
• • family of talented proteins in search of functions. Curr. Opin. Cell Biol. (1993) 5:869–876.
   Google Scholar
• MACKIE EJ, HALFTER W, LIVERANI D: Induction of tenascin in healing wounds. J. Cell Biol. (1988) 107:2757–2767.
   PubMed Web of Science ®Google Scholar
• RIOU J, UMBHAUER M, SHI D, BOUCAUT J: Tenasein: a potential modulator of cell-extracellular matrix inter-actions during vertebrate embryology. Cell (1992) 75:1–9.
   Google Scholar
• CHIQUET-EHRISMANN R: Anti-adhesive molecules of the extracellular matrix Curr. Opin. Cell Biol. (1991) 3:800–804.
   PubMed Web of Science ®Google Scholar
• MURPHY-ULLRICH JE, LIGHTNER VA, AUKIL I, YAN YZ,
   Google Scholar
• • ERICKSON HP, HOOK M: Focal adhesion integrity is downregulated by the allernatively spliced domain of human tenascin. J. Cell Biol. (1991) 115:1127–1136.
   Google Scholar
• CHIQUET-EHRISMANN R, HAGIOS C, MATSUMOTO K. The tenascin gene family. Perspect. Dev. NeurobioL (1994)
   Google Scholar
• STEINDLER DA, SETTLES D, ERICKSON HP et al.: Tenascinknock-out mice: barrel molecules and glial scars. J. Neurosci. (1991) 15:1971–1983.
   Google Scholar
• BRODKEY JA, LAYWELL ED, O'BRIEN TF et al: Focal brainInjury and upregulation of a developmentally regulated extracellular matrix protein. J. Neurosurg. (1995) 82:106–112.
   PubMedGoogle Scholar
• TUSZYNSKI GP, ROTHMAN VL, DEUTCH AH, HAMILTONBK, EYAL J: Biological activities of peptides and peptide analogues derived from common sequences present in thrombospondhi, properdin and malarial proteins. J. Cell Biol. (1992) 116:209–217.
   PubMed Web of Science ®Google Scholar
• GUO N, KRUTZSCH HC, NEGRE E, VOGEL T, BLAKE DR, ROBERTS DD: Heparin and sulphatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion. Proc. Natl. Acad. Sci. USA (1992) 89:3040–3044.
   PubMedGoogle Scholar
• SAGE E, BORNSTEIN P: Extracellular proteins that modu-late cell-matrix interactions. J. Biol. Chem. (1991) 266:14831–14834.
   PubMed Web of Science ®Google Scholar
• LIGHTNER VA: Tenascin: does it have a role in epidermal morphogenesis and homeostasis? J. Invest. Dermatot (1994) 102:273–277
   PubMedGoogle Scholar
• CHAKRAVARTI S, TAM MF, CHEUNG AE: The basementmembrane protein entactin promotes cell attachment and binds calcium ions. J. Cell Biol. (1990) 265:10597–10603.
   Google Scholar
• SANFILIPPO PJ: Cell adhesion molecules in inflamma-tion. Exp. Opin. Ther. Patents. (1995) 5(1):1–6.
   Google Scholar
• HYNES RO: Integrins: versatility, modulation and signalling in cell adhesion. Cell (1992) 69:11-25.An essential review of the field.
   Google Scholar
• HEMLER ME: VIA proteins in the integrin family: structure, functions and role on leukocytes. Ann. Rev. Immu-nol. (1990) 8:365–400.
   PubMed Web of Science ®Google Scholar
• KIM JP, ZANG K, CHEN JD, WYNN KC, KRAMER RH, WOODLEY DT: Mechanism of human keratinocyte mi-gration on fibronectin: unique roles of RGD sites and integrins. J. Cell PhysioL (1992) 151:443–450.
   PubMed Web of Science ®Google Scholar
• LARKAVA H, SALO T, HAAPASALMI K, KRAMER RH, HEINOJ: Expression of integrins and basement membrane components by wound keratinocytes. J. Clin. Invest. (1993) 92:1425–1435.
   PubMedGoogle Scholar
• CAVANI A, ZAMBRUNO G, MARCONI A, MANCA V, M.ARCHE I II M, GIANNETTI A: Distinctive integrin ex-pression in the newly formed epidermis during wound healing in humans. J. Invest. Dermatot (1993) 101:600–604.
   Google Scholar
• ADAMS JC, WATT FM: Expression of beta-1, beta-3, beta-4, and beta-5 integrins by human epithelial keratino-cytes and non-differentiated keratinocytes. J. Cell Biol. (1991) 115:829–841.
   PubMed Web of Science ®Google Scholar
• RUOSLAHTI E, NOBLE NA, KAGAMI S, BORDER WA: Inte-grins. Kidney Int. (1994) 45\(Suppl. 44):S17–22.
   Google Scholar
• HASS TA, PLOW EF: Integrin-ligand interactions: a year in review. Curr. Opin. Cell Biol (1994) 6:656–662.
   PubMedGoogle Scholar
• ROSALES C, O'BRIEN V, KORNBERG L, JULIANO R: Signal transduction by cell adhesion receptors. Bba -Rev Cancer (1995) 1242:77–98.
   PubMedGoogle Scholar
• HAAPASALMI K, MAKELA M, OKSALA 0, HEINO J, YAMADA
   Google Scholar
• •• KM, UTITO VJ, LARJAVA H: Expression of epithelialadhesion proteins and integrins in chronic inflamma-tion Am.]. Pathol. (1995) 147:193-206. Important comment on current understanding of a critical process.
   Google Scholar
• VVESKAMP G, BLOBEL CP: A family of cellular proteins related to snake venom disintegrins. Proc. Natl. Acad. Sci. USA (1994) 91:2748–2751.
   PubMedGoogle Scholar
• VERSTRAETE M, ZOLDHELYI P: Novel antithrombotic drugs in development. Drugs (1995) 49:856–884.
   PubMed Web of Science ®Google Scholar
• NIEWIAROWSKI S, MCLANE MA, KLOCZEWIAK M, STE-WART GJ: Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. Semin. Hematol. (1994) 31:289–300.
   PubMed Web of Science ®Google Scholar
• POGGI A, STELLA M, DONATI MB: The importance of blood cell-vessel wall interactions in tumour metasta-sis. Baillieres din. Haematot (1993) 6:731–752.
   PubMedGoogle Scholar
• LOFTUS JC, SMITH JW, GINSBERG MH: Integrin-mediatedcell adhesion: the extracellular face. J. Biol. Chem. (1994) 269:25235–25238.
   PubMed Web of Science ®Google Scholar
• PFAFF M, TANGEMANN K, MULLER B, GURRATH M, MULLER G, KESSKLER H, TIMPL R, ENGEL J: Selective recognition of cyclic RGD peptides of NMR defined confirmation by alpha II beta 3, alpha v beta 3, and alpha 5 beta 1 Integrins. J. Biol. Chem. (1994) 269:20233–20238.
   PubMed Web of Science ®Google Scholar
• POTTS JR, CAMPBELL ID: Fibronectin structure and as-sembly. Cum Opin. Cell. Biol. (1994) 6:648–655.
   PubMed Web of Science ®Google Scholar
• CRAIG WS, CHENG S, MULLEN DG, BLEVITT J,
   Google Scholar
• • PIERSCHBACHER MD: Concept and progress in the de-velopment of RGD-containing peptide pharmaceuti-cals. Biopolymers (1995) 37:157–175.
   Google Scholar
• KOIVUNEN E, GAY DA, RUOSLAHTI E: Selection of pep-tides binding to the alpha-5-beta-1 integrin from phage display library. J. Biol. Chem. (1993) 268:20205–20210.
   PubMed Web of Science ®Google Scholar
• SMITH JW, HU D, SATTERTHWAIT A, PINZSWEENEY S, BARBAS CF: Building synthetic antibodies as adhesive Uganda for integrins J. Biol. Chem. (1994) 269:32788–32795.
   Google Scholar
• HYNES RO: The impact of molecular biology on models for cell adhesion. Bioessays (1994) 16:663–669.
   PubMedGoogle Scholar
• GEIGER B, AYALON 0, GINSBERG D, VOLBERG T, FER-NANDEZ J, YARDEN Y, BENZEEV A: Cytoplasmic control of cell adhesion. Cold Spring Harb. Symp. Quant. Biop. (1992).
   Google Scholar
• CLARK EA, BRUGGE JS: Integrins and signal transduction pathways: the road taken. Science (1995) 268:233–239.
   PubMed Web of Science ®Google Scholar
• RICHARDSON A, PARSONS JT: Signal transduction through Integrins: a central role for focal adhesion kinase? Bioessays (1995) 17:229–236.
   PubMed Web of Science ®Google Scholar
• CHEN QM, KINCH MS, LIN TH, BURRIDGE K, JULIANO RL: Integrin-mediated cell adhesion activates mitogen-acti-vated protein kinases. j, Biol. Chem. (1994) 269:26602–26605.
   PubMed Web of Science ®Google Scholar
• PIGNATELLI M, STAMP G: Integrins in tumour develop-ment and spread. Cancer Sum. (1995) 24:113–127.
   PubMedGoogle Scholar
• HUMPHRIES MJ: Mechanisms of *and binding by line-grins. Biochem. Soc. Trans. (1994) 22:275–282.
   PubMed Web of Science ®Google Scholar
• RUOSLAHTI E, ENGVALL E (Eds.): Extracellular matrix components. Meth. Enzymol., San Diego, Academic Press, (1994) 245:638.
   Google Scholar
• RHEINWALD JD, GREEN H: Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinising colonies from single cells. Cell (1975) 6:331–334.
   PubMed Web of Science ®Google Scholar
• GLASER V: US skin replacement market could heat up. Biotechnol. (1995) 13:933.
   PubMedGoogle Scholar
• SAPOLINSKI M: Finally, a wound healing product that works? Biotech. News (1995) 15:3.
   Google Scholar
• NISHIDA T, NAKAGAWA S, NISHIBAYASHI C, TANAKA H, MANABE IL Fibronectin enhancement of corneal epithelial wound healing in rabbits in vivo. Arch. Ophthal-mol. (1984) 102:455–456.
   PubMed Web of Science ®Google Scholar
• NISHIDA T, OHASHI Y, AWATA T, MANABE R: Fibronectina new therapy for trophic corneal ulcer. Arch. Ophthal-mol. (1983) 101:1046–48.
   PubMedGoogle Scholar
• FALCONE PA, BONAVENTURA M, TURNER DC, FROMM D: The effect of exogenous fibronectin on wound breaking strength. Plastic Reconstructive Surgery (1984) 74:809–812.
   PubMed Web of Science ®Google Scholar
• REPESH LA, FITZGERALD TJ, FURCHT LT: Fibronectin Involvement in granulation tissue and wound healing In rabbits. J. Histochem. Cytochem. (1982) 30:351–358.
   PubMed Web of Science ®Google Scholar
• GINNELL F: Fibronectin and wound healing. J. Cell. Biochem. (1984) 26:107–116.
   PubMedGoogle Scholar
• ARUFFO A, STAMENKOVIC I, MELNICK M, UNDERWOOD
   Google Scholar
• • CB, SEED B: CD44 is the principal cell surface receptor for hyaluronate. Cell (1990) 61:1303–1313.
   Google Scholar
• WAYNER EA, CARTER WG: Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common. beta sub-units. J. Cell Biol. (1987) 105:1873–1884.
   PubMed Web of Science ®Google Scholar
• EJIM OS, BLUNN GW, BROWN RA: Production of artificial orientated mats and strands from plasma fibronectin: a morphological study. Biomaterials (1993) 14:743–748.
   PubMed Web of Science ®Google Scholar
• WAYNER EA, GARCIA-PARDO A, HUMPHRIES MJ, MCDON-
   Google Scholar
• • AID JA, CARTER WG: Identification and characterisation of the T-lymphocyte adhesion receptor for an alterna-tive cell attachment domain CS-1 in plasma fibronectin. J. Cell Biol. (1989) 109:1321–1330.
   Google Scholar
• GUAN J-L, HYNES RO: Lymphoid cells recognise an alternatively spliced segment of fibronectin via the integrin receptor alpha4-betal. Cell (1990) 60:53–61.
   PubMedGoogle Scholar
• HUMPHRIES MJ, AKIYAMA SK, KOMORYA A, OLDEN K, YAMADA KM: Identification of an alternatively spliced site in human plasma flbronectin that mediates cell type-specific adhesion. J. Cell Biol. (1986) 103:2637–2647.
   PubMed Web of Science ®Google Scholar
• LIOTTA IA: Tumour invasion and metastasis: role of thebasement membrane. Am. J. Pathol (1984) 117:339–348.
   PubMed Web of Science ®Google Scholar
• SOSZKA T, KNUDSEN KA, BEVIGLIA L, ROSSI C, POGGI A, NIEWIAROWSKI S: Inhibition of naurine melanoma cell matrix adhesion and experimental metastasis by albo-labrin, an RGD containing peptide isolated from the venom of Trimeresurus albolabris. Exp. Cell Res. (1991) 196:6–12.
   PubMed Web of Science ®Google Scholar
• SIGNAS C, RAUCCI G, JONSSON K, LINDGREN P-E, ANAN-THARAMAIAH GM, HOOK M, LINDBERG M: Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide se-quence lathe synthesis of biologically active peptides. Proc. Natl. Acad. Sci. USA (1989) 86:699–703.
   PubMedGoogle Scholar
• BROWN RA: Failure of fibronectin as an opsonin lathehost defense system. A case of competitive self inhibi-tion? Lancet (1983)11:1058–1060.
   Google Scholar
• PIERSCHI3ACHER MD, POLAREK jw, CRAIG WS, TSCHOPP
   Google Scholar
• • JF, SIPES NJ, HARPER JR: Manipulation of cellular inter-actions with biomateria1s towards a therapeutic out-come: a perspective. J Cell Biochem. (1994) 56:150–154.
   Google Scholar
• WARD MD, DEMOB M, HAMMER DA: Kinetics of cell detachment effect of ligand density. Ann. Biomed. Eng. (1995) 23:322–331.
   PubMed Web of Science ®Google Scholar